In the world of assisted reproduction, Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) stands as a groundbreaking tool for embryologists.
🔬 This advanced genetic screening method ensures that embryos carrying single-gene disorders—such as cystic fibrosis or sickle cell anemia—are not transferred, significantly reducing the risk of passing on inherited diseases. For embryologists, understanding PGT-M is crucial for offering patients the best chance of a healthy pregnancy.
PGT-M (formerly known as PGD—Preimplantation Genetic Diagnosis) is a specialized genetic test performed on embryos during in vitro fertilization (IVF). It screens for monogenic disorders, which are diseases caused by mutations in a single gene. Unlike PGT-A, which checks for chromosomal abnormalities, PGT-M focuses on detecting specific genetic mutations inherited from one or both parents.
Prevents Transmission of Genetic Diseases ✅
Increases the Chances of a Healthy Baby 👶
Reduces the Emotional and Financial Burden of Genetic Conditions 💰
Provides Reproductive Confidence for Carrier Parents 🧑⚕️
PGT-M is a multi-step process requiring precision and expertise:
1️⃣ Genetic Testing of Parents 🧬
Blood or saliva samples from the intended parents are analyzed to identify the specific genetic mutation.
A customized genetic probe is developed to detect the mutation in embryos.
2️⃣ IVF and Embryo Biopsy 🥚➡️🧪
Eggs are fertilized through IVF, and embryos are cultured to the blastocyst stage (Day 5 or 6).
A few cells are carefully biopsied from each embryo without harming its development.
3️⃣ Genetic Screening 🔬
The biopsied cells undergo advanced genetic analysis to identify embryos that carry, are affected by, or are free of the mutation.
4️⃣ Embryo Selection & Transfer 👶
Only mutation-free or carrier embryos (depending on parental preference) are selected for implantation, increasing the likelihood of a healthy pregnancy.
PGT-M is recommended for: ✅ Couples with a family history of genetic disorders ✅ Carrier parents of autosomal recessive or dominant conditions ✅ Patients with X-linked diseases like Duchenne Muscular Dystrophy ✅ Couples with prior affected pregnancies or children
Feature | PGT-M | PGT-A | NIPT | ||||
Detects single-gene disorders | ✅ | ❌ | ❌ | ||||
Screens for aneuploidy | ❌ | ✅ | ✅ | ||||
Performed before implantation | ✅ | ✅ | ❌ | ||||
Involves an embryo biopsy | ✅ | ✅ | ❌ | ||||
Determines embryo viability | ✅ | ✅ | ❌ |
Here are some genetic conditions that can be detected with PGT-M:
Autosomal Recessive Disorders (Both parents must be carriers)
Cystic Fibrosis
Sickle Cell Anemia
Tay-Sachs Disease
Autosomal Dominant Disorders (Only one parent needs the mutation)
Huntington’s Disease
Marfan Syndrome
BRCA1/BRCA2-Related Cancers
X-Linked Disorders (Primarily affect males)
Hemophilia
Duchenne Muscular Dystrophy
Fragile X Syndrome
✔️ Reduces the risk of passing on serious genetic conditions
✔️ Provides peace of mind to carrier parents
✔️ Increases IVF success rates by selecting the healthiest embryos
✔️ Prevents the need for pregnancy termination due to genetic disease
❌ Does not guarantee pregnancy success (Embryo quality and implantation factors still matter)
❌ Some diseases have incomplete penetrance (Mutation carriers may not always develop the disease)
❌ Requires advanced lab expertise and technology
With advancements in whole-genome sequencing, CRISPR gene editing, and AI-driven embryo analysis, PGT-M will become even more accurate, accessible, and affordable. As the field of reproductive genetics evolves, embryologists will play a crucial role in guiding patients through these cutting-edge options.
PGT-M is a game-changing tool for preventing the inheritance of life-altering genetic diseases. For embryologists, mastering PGT-M means offering patients the opportunity to build healthy families with confidence. With ongoing technological advancements, PGT-M will continue to reshape the future of reproductive medicine. 🌍💙
Blastomere Biopsy Micropipettes
Holding Micropipettes
Injection Micropipettes
Polar Body Biopsy Micropipettes
Trophectoderm Biopsy Micropipettes Bevelled
Trophectoderm Biopsy Micropipettes Flat
5 ML Round Bottom Tubes
14 ML Round Bottom Tubes
35mm Dish
50 MM Dish
60mm Dish
Center Well Dish
Customer Support
Frequently Asked Questions
Chat on WhatsApp
Chat on FaceBook Messenger
Helpful Resources
Privacy Policy
© 2025 Monash Biotech. All Rights Reserved.
Designed & Developed by Goafreet Company